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We thank Michele Poletti and colleagues for their interest in our recent population study in 
which we investigated association between schizophrenia risk alleles and 
neurodevelopmental outcomes in childhood.1 We agree that child and adolescent mental 
health services (CAMHS) are a good place to detect individuals at elevated risk for 
schizophrenia. We also agree that a developmentally-informed framework for risk assessment 
is important. Given that disorders such as schizophrenia can manifest as neurodevelopmental 
impairments earlier in life2, 3 (which may index genetic liability1), conceptualizing early risk 
as only the presentation of psychotic-like features in adolescence and adult life is likely to be 
limiting. However, the majority of impairments found to precede schizophrenia are non-
specific; cognitive, social, behavioural and emotional impairments have also been found to 
precede other psychiatric disorders, such as depression.2, 3 Thus distinguishing individuals 
who are specifically at risk for psychosis is complex and there will be challenges in 
stratifying risk appropriately. Nevertheless, for children already at elevated risk of developing 
schizophrenia (e.g. who have a parent with the disorder), increased attention to early 
neurodevelopmental impairments may aid identification of those at ultra-high risk. Findings 
from our study and the work of others4 suggest that before the typical age of illness onset, 
schizophrenia (genetic) liability may manifest as symptoms that do not resemble psychosis.  
Identifying those at risk in CAMHS is only of benefit if services are able to provide 
interventions that reduce risk but that is another challenge. Moreover accessing CAMHS 
services remains a major limitation in many countries. As we highlight in our paper1 
intervention studies that target early impairments would be useful to differentiate between 
impairments that are causally associated with later schizophrenia and those that reflect 
pleiotropy. However much more work is needed to identify interventions that are effective in 
reducing risk of future psychosis. Nevertheless, we agree with Poletti and colleagues - a first 
step towards this is to adopt a developmental conceptualization of schizophrenia. 
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